24.5 C
Vientiane
Tuesday, October 7, 2025
spot_img
Home Blog Page 142

Amorepacific Presents AI-based Skin Science Innovations and Findings at IFSCC Congress 2025

Unveiling AI architecture for virtual makeup, skin prediction algorithms, and fresh perspectives to skin aging research

SEOUL, South Korea, Sept. 22, 2025 /PRNewswire/ — At the 35th International Federation of Societies of Cosmetics Chemists (IFSCC) Congress held in Cannes, France from September 15 to 18, Amorepacific unveiled innovations and research findings on topics including AI-driven virtual makeup, skin prediction algorithms, and advanced analyses of skin microbiomes and metabolites.

Myeongjin Goh from the Amorepacific R&I Center presents “Development of the Generative AI-based Pipeline Architecture for Advanced Virtual Makeup” at the 35th IFSCC Congress.
Myeongjin Goh from the Amorepacific R&I Center presents “Development of the Generative AI-based Pipeline Architecture for Advanced Virtual Makeup” at the 35th IFSCC Congress.

Established in 1959, the IFSCC Congress is the world’s largest cosmetics science conference serving as a forum for leading cosmetic researchers around the world. This year’s event, themed “The Future is Science,” featured two oral presentations and five poster presentations by Amorepacific researchers, aimed at further accelerating biological research on aging and integration of AI in driving scientific advancements.

Namely, Researcher Myeongjin Goh from the Amorepacific R&I Center presented “Development of the Generative AI-based Pipeline Architecture for Advanced Virtual Makeup.” Co-developed with Korea Advanced Institute of Science & Technology, the technology leverages generative AI and image generation techniques tailored for makeup applications. It enables precise analysis of facial shapes and features, and utilizes extensive data on makeup trends to recommend personalized styles, offering users realistic experiences of AI-recommended virtual makeup colors and styles.

Researcher Eunbi Ko delivered a presentation titled “Application of a Skin Prediction Algorithm for Personalized Skincare Services with Clinical Outcomes.” Conducted at Amorepacific’s in-house customer research center City Lab, the study validated skin improvement results through AI-based skin prediction algorithms and customized skincare programs. Building on the ‘Future Skin Prediction Algorithm’ and ‘Customized Skincare Solution’ first presented at the 2022 IFSCC Congress in London, the research proved effectiveness based on real customer reviews and clinical trials.

In a poster presentation titled “Integrated Analysis of the Age-related Microbiome and Metabolites in Korean Women’s Skin,” Researcher Kil Sun Myoung shared insights from an integrated analysis of skin microbiomes, physiological traits, and metabolites of Korean women across different age groups. Identifying age-specific skin traits, the research revealed that microbiome profiles among women in their 20s and 60s were not divided into two, but three distinct clusters — offering a fresh perspective on research into skin aging.

Byung-Fhy Brian Suh, CTO and Head of Amorepacific R&I Center, said, “Amorepacific is advancing toward its 2035 vision, centered around the company’s ‘Ageless’ and ‘AI First’ strategies. The Amorepacific R&I Center will deeply integrate AI technology across all areas of research and development to expand the boundaries of skin science and set new standards for future innovative beauty.”

Hon’ble CM of Delhi, Smt. Rekha Gupta, Inaugurates Apollo Athenaa – Asia’s First Dedicated Cancer Centre for Women

NEW DELHI, Sept. 22, 2025 /PRNewswire/ — Apollo Hospitals Enterprise Ltd (AHEL) recently announced the launch of Apollo Athenaa – Asia’s First Dedicated Cancer Centre for Women, located in E2-E3, Defence Colony, New Delhi. The centre was inaugurated by the Hon’ble Chief Minister of Delhi, Smt. Rekha Gupta, in the presence of Dr. Prathap C Reddy, Founder-Chairman, Apollo Hospitals Group; Ms. Bansuri Swaraj, Member of Parliament, New Delhi; Shri Neeraj Basoya, Member of the Legislative Assembly; Ms. Preetha Reddy, Executive Vice Chairperson, AHEL; and Mr. Harshad Reddy, Director, Group Oncology, AHEL.

New Delhi Chief Minister Smt. Rekha Gupta, along with Member of Parliament Ms. Bansuri Swaraj; Dr. Prathap C Reddy, Founder-Chairman, Apollo Hospitals Group; Ms. Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals Enterprise Ltd (AHEL); and Mr. Dinesh Madhavan, President, Group Oncology and International (AHEL)
New Delhi Chief Minister Smt. Rekha Gupta, along with Member of Parliament Ms. Bansuri Swaraj; Dr. Prathap C Reddy, Founder-Chairman, Apollo Hospitals Group; Ms. Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals Enterprise Ltd (AHEL); and Mr. Dinesh Madhavan, President, Group Oncology and International (AHEL)

Speaking at the inauguration, Smt. Rekha Gupta, Hon’ble Chief Minister of Delhi, said: “Cancer care for women is a deeply sensitive issue, and it gives me great satisfaction to see us moving towards real empowerment for women. Apollo Athenaa will stand as a milestone in cancer care, ensuring dignity, security, and privacy for every woman.”

In the recent past, more women than men have been diagnosed with cancer, notably with cancers in women accounting for the highest incidence. A new study from ICMR’s National Cancer Registry Programme (NCRP) has revealed that breast and cervical cancers are the most common types of cancers among Indian women.

Dr. Prathap C Reddy, Founder-Chairman, Apollo Hospitals Group, said: “Apollo Athenaa represents a new horizon in women’s healthcare, where cutting-edge science meets compassion, and every woman is assured of dignity and timely care. It reflects our enduring belief that India can lead the world not just in medical innovation, but in reimagining healthcare as a force for hope and humanity.”

Ms. Bansuri Swaraj, Member of Parliament, New Delhi, said, “As cancer is rising at an alarming pace, the Government of India has introduced robust policies and strategic interventions to enhance prevention, early detection, treatment, and patient care nationwide. Our government is also consistently prioritising women’s health. Apollo’s transformative initiative and setting a global benchmark in women-centric cancer care will complement the national health mission.”

Ms. Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals Enterprise Ltd, said: “Apollo Athenaa is not just a hospital—it’s a movement, a symbol of progress, empathy, and commitment to women’s health. By focusing exclusively on cancers affecting women, Athenaa offers personalised care that respects dignity, enables early detection, improves outcomes, and restores hope.”

Website: https://www.apollohospitals.com/hospitals/apollo-athenaa-womens-cancer-centre

 

 

PHASE Scientific Launches World’s Largest Urine-Based Cervical Cancer (HPV) Screening Clinical Study, Marking New Era of Non-Invasive Cervical Cancer Screening

GUANG’AN, China, Sept. 22, 2025 /PRNewswire/ — PHASE Scientific International Limited (“PHASE Scientific”) today announced the official launch of the world’s largest clinical study for urine-based cervical cancer (HPV) screening, with the first site established in Guang’an, Sichuan Province, China.

This study is led by Peking University Shenzhen Hospital, with participation from West China Guang’an Hospital of Sichuan University and technical and diagnostic support by PHASE Scientific. The study applies PHASE Scientific’s proprietary PHASiFY™ urine-based DNA concentration technology, aiming to explore a scalable, accessible approach to cervical cancer prevention that delivers next-level public health impact with scientific innovation.

This prospective study plans to include 17,000 eligible women, evaluating the clinical performance of urine-based HPV DNA testing in primary screening settings for cervical intraepithelial neoplasia (CIN) and cervical cancer. Notably, it will also be the first in the world to validate urine-based methylation testing and artificial intelligence visual evaluation (AVE) from colposcopy images within the same cohort. The study sets three world records, namely the largest global clinical study on urine-based HPV subtyping for primary cervical cancer screening, the first and largest prospective study on urine-based genetic methylation testing for cervical cancer screening, and the first population validation in China of a handheld AI-enabled colposcopy device based on international standards.

By combining non-invasive sampling, high-efficiency molecular detection, and AI-powered diagnostics, the study aims to drive cervical cancer prevention into a new era of “vaccination + non-invasive screening.” Experts across the field believe this dual-track approach could provide valuable insights to help meet the World Health Organization’s (WHO) 90-70-90 targets for cervical cancer elimination by 2030. The study also seeks to establish a practical and localized prevention model suited to China’s national context – one that improves screening accessibility and compliance.

On September 11, China’s State Council announced that HPV vaccination will be included in the national immunization program, offering free vaccines to school-aged girls. While this policy milestone has raised national awareness about cervical cancer prevention, it also highlights new challenges: HPV vaccines cover only select virus types, and are most effective when administered before exposure, typically in younger, uninfected populations. The preventive impact on cervical cancer incidence could take 10-20 years to manifest. Meanwhile, women aged 35-64 remain the highest-risk group, and vaccination alone is unable to address the short-term disease burden, making screening an irreplaceable tool in the current phase.

However, traditional clinician-collected sampling often presents psychological and logistical barriers for many women. According to the Chinese Center for Disease Control and Prevention (China CDC), the screening coverage rate among women aged 35-64 is only 51.5%, far below the WHO’s 70% benchmark. Thus, finding more accessible, non-invasive, and user-friendly screening methods has become a critical priority in advancing cervical cancer prevention.

Professor Wu Ruifang, Director of the National Cervical Cancer Early Detection and Treatment Demonstration Center at Peking University Shenzhen Hospital, and the study’s principal investigator, said, “Self-sampling technologies for cervical cancer screening have been validated globally over the past two decades as effective tools to increase screening coverage. We will include urine-based HPV testing as an innovative self-sampling technology in this study. While other teams have explored this approach in the past, sensitivity has long been a challenge. Our previous research demonstrated that when paired with PHASiFY™ technology, urine-based HPV testing can achieve sensitivity comparable to clinician-collected and vaginal self-collected samples. We believe that urine testing is non-invasive, convenient, and more acceptable to women. This makes it an important lever for screening participation rate increase and public health policy implementation.”

Professor Wu continues, “This study represents a unique combination of technology, scientific research and public health. It will not only benefit a broad female population, but also provide vital real-world data to support the development of national cervical cancer prevention guidelines and self-sampling standards.”

The study utilizes PHASE Scientific’s proprietary PHASiFY™ technology, which concentrates trace amounts of HPV DNA in urine by more than 10,000 times, achieving 93.42% sensitivity for high-risk HPV detection, and over 97% concordance with clinician-collected vaginal swabs analyzed using the Roche Cobas system. This research, led by the Peking University Shenzhen Hospital team, was recently recognized with the Best Clinical Research Abstract Award at the 2025 Annual Meeting of the American Society for Colposcopy and Cervical Pathology (ASCCP) – the society’s highest honor, and the first time a Chinese research team has received this distinction, underscoring the international recognition of PHASiFY™’s scientific and clinical value.

Xiao Rongxing, Deputy Director of the Guang’an Municipal Health Commission, commented on the significance of the study at Guang’an, “There are around 4 million women in Guang’an, with around 2 million of them in the target age group for HPV screening. However, there remains a screening coverage gap for women living in urban areas besides the low-income groups. This clinical study directly addresses that gap and will have a significant impact on cervical cancer prevention in our city.”

Jenny Chiu, Vice President of PHASE Scientific, stated during her speech in the kick-off ceremony, “This project is a major milestone in the advancement of non-invasive cervical cancer screening. PHASE Scientific will invest in rolling out comprehensive self-sampling services, including urine-based HPV testing, AI-powered colposcopy, and cloud-based data platforms. We believe that with just a cup of urine, we can drive a future of more inclusive, accessible and precise healthcare for women.”

Speaking on the company’s plans on the Chinese mainland, Gary Guan, General Manager of PHASE Scientific China, said, “At the core of our PHASiFY™ platform is biomarker concentration from clinical samples – a technology that can be applied to many diseases. In China, we’ve launched both male and female versions of the urine-based HPV testing, along with a full-suite of cervical cancer and HPV prevention solutions. We’re also advancing multi-disease detection from a single urine sample, enabling screening for sexually transmitted infections (STIs) and other cancers at the same time.”

“We are actively partnering with medical institutions, health checkup providers, insurers, elder care providers, and online platforms to drive public health education and promote access to testing. Our goal is to provide users with convenient, accurate diagnostics, and to build a full-spectrum health solution that integrates testing, intervention, and prevention.” Gary added.

From the inclusion of HPV vaccines in the national immunization program to the simultaneous achievement of three world records, PHASE Scientific is bridging the gap between “the first shot of the vaccine” and “the last mile of diagnostics” – leading the global shift toward non-invasive cervical cancer screening powered by its innovation. With aligned progress in technology, research, and distribution, PHASE Scientific helps to reshape global cervical cancer prevention and contribute to the Healthy China 2030 vision.

*Note to editor: The WHO’s Global Strategy to Accelerate the Elimination of Cervical Cancer sets a threshold for all countries of an incidence rate of less than 4 cases per 100,000 women. It also establishes the following targets to be achieved by 2030 in all countries: 90% HPV vaccination coverage, 70% screening coverage, and 90% access to treatment for cervical pre-cancer and cancer, including access to palliative care.

About PHASE Scientific

PHASE Scientific International Limited (“PHASE Scientific”) is a fast-growing biotech company with a mission to inspire a new state of health through innovative diagnostics and healthcare solutions. With operations in the U.S., mainland China, and Hong Kong SAR, PHASE delivers novel diagnostic tools and services for cancer and infectious diseases using proprietary technologies, empowering better disease detection, diagnosis, and management.

PHASE Scientific’s products and services have received certifications from the U.S. Food and Drug Administration (FDA), the European Union CE, and regulatory agencies in various countries, providing over 100 million testing products and services in more than 30 countries worldwide.

PHASE Scientific has recently completed a US$34 million Series A funding round, representing the largest Series A raise in Asia’s diagnostic technology sector since 2019. Other supporters include Gates Foundation, and US governmental agencies National Science Foundation and National Institute of Health. For more information, please visit phasescientific.com.

About PHASIFY™

PHASIFY™ is the world’s first urine concentration technology designed for molecular diagnostics, setting a new industry benchmark by capturing approximately 10 times more target analytes from urine specimens compared to the current gold standard. This advanced mechanism enables the concentration and purification of unlimited volumes of urine, dramatically increasing the sensitivity and accuracy of disease detection.

This proprietary innovation uniquely positions PHASE Scientific as the only player in the urine-based liquid biopsy diagnostics field, with proven clinical performance for multi-cancer detection. With a non-invasive and painless approach, PHASIFY™ empowers convenient sample collection, unlocking new possibilities for early, accessible, and comprehensive disease screening and diagnosis.

Media Contact

PHASE Scientific
pr@phasesci.com

FGS Global
PhaseSci@fgsglobal.com

K-Beauty Lives in 2025: IUNIK’s Minimalist Beta-Glucan Breakthrough

SEOUL, South Korea, Sept. 22, 2025 /PRNewswire/ — Do you ever feel like you’re doing too much for your skin yet still battling dryness? You’re not alone. In 2025, many people are discovering that dryness isn’t a sign you need a skincare routine with 10 steps, but rather good performance products that target specifically your needs and work on your skin. This realisation has given rise to skin streaming, a trend that favours streamlined routines with products that multitask. Among the standouts is IUNIK’s Beta‑Glucan Power Moisture Serum, a serum that takes a friendly, no‑frills approach to hydration.

IUNIK Beta-Glucan Power Moisture Serum
IUNIK Beta-Glucan Power Moisture Serum

A familiar problem: thirsty skin

Daily life does a number on our skin. Air‑conditioned offices, harsh weather and frequent mask wearing all sap moisture. The result? Tightness, dullness and that uncomfortable feeling of a face that never quite feels quenched. While there are countless formulas promising miracles, many of them layer active after active and leave you wondering whether all that complexity is necessary. IUNIK thinks the answer is no. Their serum zeroes in on hydration with a single hero ingredient and minimal extras.

Meet beta‑glucan, your skin’s new drinking buddy

Beta‑glucan may sound like something from a lab, but it’s a natural polysaccharide found in oats, mushrooms and yeast. Dermatologists praise it for being both deeply hydrating and soothing. It acts like a sponge, pulling water to the skin and locking it in while reinforcing the protective barrier. Because it also calms redness and irritation, beta‑glucan suits sensitive and reactive skin types, the very people who often fear that new products will cause more harm than good.

What makes IUNIK’s formula different

Many hydrating serums play host to a long list of actives. IUNIK takes a different tack. The ingredient list is strikingly short: beta‑glucan, water, glycerin and a few safe solvents. It’s free of fragrances, essential oils and harsh alcohols, which keeps the risk of irritation low. Independent ingredient analyses list the serum’s top benefits as hydrating and relieving dry, tight skin, underscoring the formula’s restraint, no extra actives to complicate layering, just a reliable water magnet. Instead of cramming every popular ingredient into one bottle, IUNIK focuses on one that addresses dryness and leaves the extras out.

Viewed neutrally, beta-glucan is a well-documented humectant that draws and holds water at the skin’s surface while helping the barrier feel calmer, exactly what dry, tight complexions need. In this serum that role is supported by a short, fast-absorbing base with no added fragrance or essential oils and no heavy oils. The composition is non-comedogenic and widely considered fungal-acne safe, so it slots into sensitive and acne-prone routines without adding new variables. In short, instead of leaning on marketing superlatives, the formula relies on established humectancy and low-irritant design to solve everyday dryness, reassuring for U.S. shoppers who prefer mild, minimalist steps that still deliver.

Does mild mean ineffective?

It’s a reasonable question. There’s a long‑standing assumption that mild products must be weak. Yet beta‑glucan’s abilities go beyond basic moisture. It not only hydrates but also soothes irritation and aids barrier repair. SkinSort lists reduced irritation and redness among its benefits. Amazon’s description emphasises that the serum delivers instant and long‑lasting moisturisation. The simplicity of the formula isn’t a lack of ambition; it’s a deliberate strategy to focus on what dry skin actually needs.

Fitting into a streamlined routine

Because the texture is a light, watery gel, the serum absorbs quickly and plays well with others. People who are simplifying their routines can use it morning and night as their hydration step. Those who still enjoy actives like vitamin C, azelaic acid, or retinoids can slot the serum in without fear of pilling or irritation. By covering the hydration and calming base, it frees you to be more selective about additional products.

The takeaway for sceptical shoppers

For U.S. consumers who are wary of minimalist products, IUNIK’s approach offers a new perspective. A shorter ingredient list doesn’t mean lower performance; in this case, it means every component has a job. If your main issue is dryness, you don’t need a cocktail of unrelated actives, you need a humectant that works and a formula that won’t upset your skin. That’s exactly what beta‑glucan and this serum provide.

In a beauty landscape increasingly defined by doing less, IUNIK’s Beta‑Glucan Power Moisture Serum demonstrates that simple, gentle formulations can punch above their weight. For anyone tired of complicated routines and still hunting for real hydration, it’s a persuasive reminder that sometimes the simplest solution is the best.

For more information about IUNIK and its products, visit www.iunik.com.

Media Contact:
Marketing Manager Joan T joan@iunikcos.com

XTransfer Joins in 2025 Conference on the Bund

CEO Explores New Opportunities in Foreign Trade Finance


SHANGHAI, CHINA – Media OutReach Newswire – 22 September 2025 – XTransfer, the World’s Leading & China’s No.1 B2B Cross-Border Trade Payment Platform, was recently invited by the Global Finance & Technology Network (GFTN) to attend the highly anticipated annual technology event, 2025 Inclusion·Conference on the Bund in Shanghai. Bill Deng, Founder and CEO of XTransfer, was invited as a panellist for the session, “The Southeast Asia Payments Opportunity”, where he joined guests from GFTN, HSBC and Stripe, to engage in in-depth discussions on digitalisation and opportunities in emerging markets.

Bill Deng, Founder and CEO of XTransfer (second from left), was invited to participate in a panel at the 2025 Inclusion·Conference on the Bund.
Bill Deng, Founder and CEO of XTransfer (second from left), was invited to participate in a panel at the 2025 Inclusion·Conference on the Bund.

Data released by XTransfer for cross-border SMEs shows that exporters are accelerating their embrace of emerging economies. Chinese exporters’ reliance on the U.S. market continues to decline: the share of transactions from U.S. buyers has fallen from 22% in 2018 to 9% in 2025. Meanwhile, Southeast Asia has emerged as the largest source region, accounting for 24%. Demand in Latin America and Africa is also growing rapidly, and XTransfer is expanding its service capabilities in markets such as Mexico, Brazil, Ghana, and Egypt. A McKinsey report released at the Bund Conference likewise noted that Asia has become the most dynamic region for global trade, with strong and fast adoption of digital technologies, providing fertile ground for the digital transformation of foreign trade enterprises.

From an industry structure perspective, the “new three”, lithium batteries, new energy vehicles, and solar cells, together with high-tech product exports such as auto parts and consumer electronics, are raising the bar for cross-border payments: faster capital turnover, more precise compliance and risk controls, and high availability across multiple currencies and regions. Through self-developed risk and compliance infrastructure, a partner banking network, and localised services, XTransfer platform is continuously enhancing the stability and coverage of B2B payments.

To address the long‑standing challenges faced by SMEs, including high costs, slow settlement, and compliance uncertainty, XTransfer proposes technology‑driven solutions. On the one hand, XTransfer has formulated a new industry standard called X-Net, focusing on improving capital flow and AML risk management to drive industry standardisation. On the other hand, an AI-driven risk control system enables “non-intrusive transaction reviews”, with relevant indicators improved from 96% to 99%, ensuring compliant and secure transactions while minimising interference with clients’ operations to enhance transaction continuity and capital efficiency.

In terms of payment experience, XTransfer continues to advance its product roadmap of making “B2B payments as simple as scanning a QR code”, focusing on streamlining processes and improving timeliness, from account opening and collections/payments to reconciliation and write-offs, to help foreign trade enterprises shorten cash conversion cycles and reduce fees & operating costs. It also leverages multi-dimensional data verification and supply‑chain-based solutions to improve the efficiency of trade authenticity verification.

Bill Deng, Founder and CEO of XTransfer, stated that XTransfer now serves over 700,000 clients globally, 47% of which are overseas enterprises. He expects the company’s transaction volume to grow tenfold over the next five years, describing this as a “mobile payment revolution” in the cross‑border B2B arena.

On the exploration of stablecoins, Bill noted at the Bund Conference that as a payment tool built on blockchain infrastructure, stablecoins possess attributes such as traceability, real-time verification, and programmability. They are poised to ease the time and cost burdens caused by multi-layer correspondent banking clearing in cross-border B2B settlement. Within a compliant framework, XTransfer will adopt a dual risk‑control mechanism of “on-chain behaviour analytics + off-chain trade authenticity verification”, advancing productisation prudently to offer options for more efficient cross-border settlement in the future. Bill further predicted that within three years, import‑export enterprises’ wallets will be “dual‑currency” wallets supporting both fiat currencies and stablecoins. At the same time, Bill emphasised that related applications will strictly adhere to current regulatory requirements and be rolled out steadily.

Bill added that XTransfer will continue to increase its investment in emerging markets, working with global partners to upgrade cross-border B2B payment infrastructure, and providing SMEs with more convenient and secure global capital connectivity, thereby making foreign trade operations faster, steadier, and more cost-effective.

Hashtag: #XTransfer #theBundConference #Crossborder #Payment #SMEs #ASEAN #EmgergingMarkets





The issuer is solely responsible for the content of this announcement.

Alfaisal University Secures LUYTEN 3D Printer to Advance Innovation in Architecture and Sustainability

RIYADH, Saudi Arabia, Sept. 22, 2025 /PRNewswire/ — Alfaisal University has announced the acquisition of a cutting-edge 3D construction printer from Australian company LUYTEN 3D. The new technology will equip students and researchers in the University’s Department of Architectural Engineering with hands-on experience, enabling them to explore the future of construction and drive innovative, sustainable building solutions.

Dr Abdulrahman Ahmed Alymani, Chair of the Department and Assistant Professor of Architecture Engineering, said the decision is part of a broader strategy to integrate emerging technologies into the university’s curriculum and research agenda.

The department’s acquisition of LUYTEN’s 3D printer is expected to significantly expand opportunities for research and experimentation in areas such as digital fabrication, material science, and construction sustainability. A key focus will be on using earthen and low-carbon materials to reduce costs, environmental impact, and improve housing options in arid environments.

LUYTEN’s 3D printer was selected after extensive evaluation for its compatibility with sustainable materials, seamless CAD/BIM integration, and proven reliability in extreme climates. The company’s alignment with climate-resilient, low-carbon construction practices made it the ideal partner for the university’s ambitions.

This acquisition also aligns with the Kingdom of Saudi Arabia’s Saudi Vision 2030, particularly in the areas of smart construction and sustainable urban development. As the Kingdom rolls out innovative housing initiatives and large-scale 3D printing projects in cities like Riyadh and NEOM, Alfaisal University positions itself as a leader in educating the next generation of architects and engineers ready to contribute to this national transformation.

The announcement was marked by a special event celebrating the opening of Alfaisal University’s new Civil Engineering Lab. Assoc Prof Dr Ahmed Mahil, Founder, CEO and Global President of LUYTEN 3D, co-hosted the ceremony alongside Dr Abdulrahman Ahmed Alymani. The occasion highlighted the Architecture Engineering Department’s acquisition of LUYTEN 3D’s Platypus X1 Printer, the world’s fastest-selling 3D construction printer.

Quotes attributable to Ahmed Mahil, CEO and Global President of LUYTEN 3D

“We are proud to be enablers of the fourth industrial revolution, driving a holistic vision that addresses every part of the value chain, from teaching and research to applied innovation, industry partnerships, and large-scale commercial projects.”

“By bridging academic excellence with real-world impact, we are ensuring that the next generation of engineers, researchers, and entrepreneurs are equipped to lead in sustainable and transformative technologies.”

Quotes attributable to Dr Abdulrahman Ahmed Alymani, Chair and Assistant Professor, Architecture Engineering Alfaisal University

“Alfaisal University has acquired one of the world’s most advanced 3D concrete printers from Luyten. This milestone supports the University’s mission to equip its laboratories with state-of-the-art facilities, fostering innovation, research, and hands-on learning in advanced construction technologies.” Dr Alymani said

“As the field of architecture rapidly evolves, it’s crucial our students are not only aware of emerging technologies but are equipped to apply them practically,” Dr Alymani said.

“With growing global and regional interest in sustainable, efficient construction methods – particularly in the MENA region – we believe now is the right time to embrace 3D printing in both education and research.”

“Our students are incredibly enthusiastic,” Dr Alymani added. “They’re already proposing projects that challenge traditional construction methods and explore how 3D printing can solve real-world challenges.”

About LUYTEN 3D:
LUYTEN 3D’s cutting-edge 3D printing technology allows builders to complete construction projects that would traditionally take months or years in a fraction of the time.
The 3D concrete printing revolutionary technology enables 60 percent reduction of construction waste, 70 percent reduction of production time, and 80 percent reduction of labour costs when compared to hands-on construction projects.
https://www.luyten3d.com 

About Alfaisal University:
Alfaisal University is a private university in Riyadh, Saudi Arabia, located in the compound enclosing the vicinity of the al-Ma’dhar Palace. Established in 2002, the institute offers courses in various subjects up to post graduation and is named after King Faisal bin Abdulalziz.
https://www.alfaisal.edu/en/

 

Govee Launches Permanent Outdoor Lights Prism, Ushering in a New Era of Outdoor Lighting

 As the creator of the category, Govee advances innovation with the industry’s first Triple-Color Effect Optics

Bellevue, Wash., Sept. 22, 2025 /PRNewswire/ — Govee, a global leader in smart lighting innovations, today announced the official launch of the Govee Permanent Outdoor Lights Prism. Featuring the industry’s first Triple-Color Effect Optics, the Govee Permanent Outdoor Lights Prism integrates three independently controlled color zones within one lighting head, unlocking limitless DIY possibilities and elevating the creative potential of outdoor lighting.

Govee Launches Permanent Outdoor Lights Prism, Ushering in a New Era of Outdoor Lighting
Govee Launches Permanent Outdoor Lights Prism, Ushering in a New Era of Outdoor Lighting

Govee is the first in the industry to create permanent outdoor lights, and led the category with the Govee Permanent Outdoor Lights 2 and the Govee Permanent Outdoor Lights Pro, which introduced cuttable and splicable design with both white light and ambient light. Govee has consistently driven the evolution of the permanent, customisable outdoor lighting, and with the Govee Permanent Outdoor Lights Prism, Govee once again redefines the standard, setting a new benchmark in optical engineering and user experience.

“At Govee, we believe that permanent outdoor lighting should go beyond decoration. It is about offering more ways for users to personalize their homes. With the Govee Permanent Outdoor Lights Prism, we focused on enabling deeper DIY possibilities so users can treat their homes as a stage for self-expression,” said Eric Wu, CEO of Govee. “We are proud to introduce this next generation of innovation, continually pushing the boundaries of what outdoor lighting can be”.

A First-of-Its-Kind Optical Breakthrough

The Govee Permanent Outdoor Lights Prism is the industry’s first and only flagship permanent outdoor lights to feature a triple-color lighting effect with a dynamic optical design. Govee’s R&D team completed thousands of tests and refinements, to create a completely customized optical structure that fits into a compact design, resulting in that looks perfectly balanced to the human eye, with each zone blending smoothly without any overlap.

True-to-Life Color with Limitless DIY Possibilities

The Govee Permanent Outdoor Lights Prism incorporates custom LEDs and proprietary chipsets that surpass the industry average by more than 150%, achieving a significant performance improvement while retaining a refined and lightweight design.

With Govee’s proprietary LuminBlend™ color management system, the Permanent Outdoor Lights Prism can produce 16 million true-to-life colors and create seamless gradients that shift smoothly from subtle tones to vivid, saturated displays. The higher LED density and advanced color management unlock a virtually limitless DIY experience, enabling households to transform their exteriors for any holiday or celebration into personalized canvases of light and creativity.

TÜV Rheinland Certification for Proven Durability

The Govee Permanent Outdoor Lights Prism has been awarded the TÜV Rheinland certification for product durability and reliability. According to TÜV Rheinland’s independent testing, it demonstrated continuous and reliable performance in extreme environments ranging from -30°C to 60°C. The certification also confirmed the products’ robust construction, with wiring tested to withstand a tensile strength of up to 30kg, ensuring safety and long-term endurance.

The Govee Permanent Outdoor Lights Prism is built to perform in any season, featuring industry-leading IP68 waterproof protection that ensures the lights remain reliable even in heavy rain. With an ultra-long lifespan of up to 50,000 hours and an operating range from -22°F to 140°F, it delivers dependable lighting year-round.

Smart Control and Smart Living

The Govee Permanent Outdoor Lights Prism offers an intelligent lighting experience powered by the Govee Home App. Users can unlock more than 100 preset scenes, explore AI-powered dynamic lighting effects that adapt in real time, enjoy immersive DreamView synchronization, or let the lights move to the rhythm with Music Mode.

Like all Govee lights, the Govee Permanent Outdoor Lights Prism offers seamless smart control and ecosystem integration. Control your lights effortlessly using the Govee Home App, voice commands through Amazon Alexa or Google Home, or expand your setup with Matter compatibility. 

Pricing and  Availability

The Govee Permanent Outdoor Lights Prism is available starting today at Govee.com and Amazon, priced at $539.99 for 100ft, $699.99 for 150ft, and $859.99 for 200ft.

About Govee

Govee has been revolutionizing the smart living experience with innovative, ambient lighting solutions since 2017. From living spaces, gaming setups, and outdoor areas, Govee’s smart home tech is not just visually stunning, but also functional – transforming small everyday moments into more personalized and brighter engaging lighting experiences. Embracing the idea that users should “Life is Colorful” and push the boundaries of what lighting can do by blending design, and utility. To learn more about Govee, please visit govee.com.

Study Reveals Gaps in Childhood Vaccination Across Laos

Study Reveals Gaps in Childhood Vaccination Across Laos
This image is used only for representational purpose (photo credit: UNICEF/UN0198111/SNazer)

Nearly 15 percent of children aged 12-23 months in Laos remain unvaccinated, according to a study shared on 20 September by the Faculty of Public Health at the University of Health Sciences.